X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
abraxane (107) 107
index medicus (66) 66
paclitaxel (61) 61
humans (60) 60
oncology (42) 42
chemotherapy (41) 41
albumin-bound paclitaxel (38) 38
cancer (35) 35
nab-paclitaxel (34) 34
female (32) 32
pharmacology & pharmacy (31) 31
animals (28) 28
docetaxel (28) 28
paclitaxel - administration & dosage (25) 25
taxol (20) 20
breast-cancer (18) 18
gemcitabine (18) 18
nanoparticles (18) 18
albumin (17) 17
drug delivery systems (17) 17
male (17) 17
paclitaxel - therapeutic use (17) 17
breast cancer (16) 16
cremophor-free (16) 16
phase-iii trial (16) 16
albumins - administration & dosage (15) 15
antineoplastic agents - therapeutic use (15) 15
cell line, tumor (15) 15
drugs (15) 15
metastasis (15) 15
abi-007 (14) 14
care and treatment (14) 14
mice (14) 14
drug therapy (13) 13
middle aged (13) 13
paclitaxel - adverse effects (13) 13
aged (12) 12
albumins - therapeutic use (12) 12
antimitotic agents (12) 12
antineoplastic agents (12) 12
vehicles (12) 12
neoplasms - drug therapy (11) 11
research (11) 11
taxane (11) 11
treatment outcome (11) 11
antineoplastic combined chemotherapy protocols - therapeutic use (10) 10
drug delivery (10) 10
drug-delivery (10) 10
formulation (10) 10
health aspects (10) 10
nanoscience & nanotechnology (10) 10
nanotechnology (10) 10
paclitaxel - chemistry (10) 10
tumors (10) 10
albumins - adverse effects (9) 9
antineoplastic agents, phytogenic - administration & dosage (9) 9
breast neoplasms - drug therapy (9) 9
cell lung-cancer (9) 9
lung neoplasms - drug therapy (9) 9
medicine & public health (9) 9
metastatic breast-cancer (9) 9
pancreatic cancer (9) 9
review (9) 9
survival (9) 9
therapy (9) 9
tumor (9) 9
adult (8) 8
article (8) 8
cancer therapies (8) 8
carcinoma, non-small-cell lung - drug therapy (8) 8
chemistry, multidisciplinary (8) 8
clinical trials as topic (8) 8
complications and side effects (8) 8
deoxycytidine - analogs & derivatives (8) 8
dosage and administration (8) 8
lung cancer, non-small cell (8) 8
nanoparticle (8) 8
nanoparticles - chemistry (8) 8
phase-i (8) 8
phase-ii trial (8) 8
solid tumors (8) 8
analysis (7) 7
antineoplastic agents - administration & dosage (7) 7
antitumor-activity (7) 7
biotechnology & applied microbiology (7) 7
carboplatin (7) 7
medicine (7) 7
ovarian cancer (7) 7
patient outcomes (7) 7
pharmacokinetics (7) 7
respiratory system (7) 7
usage (7) 7
albumins - pharmacokinetics (6) 6
cremophor el (6) 6
expression (6) 6
folfirinox (6) 6
hypersensitivity reactions (6) 6
non-small cell lung cancer (6) 6
paclitaxel - pharmacokinetics (6) 6
paclitaxel - pharmacology (6) 6
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Advanced Drug Delivery Reviews, ISSN 0169-409X, 12/2017, Volume 122, pp. 20 - 30
Paclitaxel (PTX) is one of the three most widely used chemotherapeutic agents, together with doxorubicin and cisplatin, and is first or second line treatment... 
Oncology | Taxol | Nanomedicine | Abraxane | Nanotechnology | Paclitaxel
Journal Article
International Journal of Nanomedicine, ISSN 1176-9114, 12/2013, Volume 9, Issue 1, pp. 209 - 221
Journal Article
Nanomedicine (London, England), ISSN 1743-5889, 05/2019, Volume 14, Issue 10, pp. 1323 - 1341
The poor solubility of paclitaxel (PTX), the most commonly used anticancer drug (Taxol ), has long hindered the development of successful formulations. In... 
paclitaxel | 1ST-LINE TREATMENT | ADVANCED BREAST-CANCER | LEP-ETU | NAB-PACLITAXEL | nano-formulation | Abraxane (R) | NANOSCIENCE & NANOTECHNOLOGY | OVARIAN-CANCER | ANTITUMOR-ACTIVITY | chemotherapeutic agents | PHASE-III TRIAL | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | ALBUMIN-BOUND PACLITAXEL | IN-VIVO | Taxol (R) | DOCOSAHEXAENOIC ACID-PACLITAXEL
Journal Article
INTERNATIONAL JOURNAL OF NANOMEDICINE, ISSN 1176-9114, 2009, Volume 4, Issue 1, pp. 99 - 105
Breast cancer is the most common type of malignancy diagnosed in women. In the metastatic setting this disease is still uncurable. Taxanes represent an... 
paclitaxel | CREMOPHOR-FREE | GENE DELIVERY | HUMAN SERUM-ALBUMIN | breast cancer | CLINICAL-ASPECTS | NANOSCIENCE & NANOTECHNOLOGY | DELIVERY-SYSTEM | THERAPY | Abraxane | TAXOL | ENDOTHELIAL-CELLS | nanotechnology | PHARMACOLOGY & PHARMACY | NANOPARTICLE FORMULATION | PHASE-I
Journal Article
JOURNAL OF THORACIC ONCOLOGY, ISSN 1556-0864, 11/2017, Volume 12, Issue 11, pp. S1960 - S1961
Conference Proceeding
Small, ISSN 1613-6810, 02/2019, Volume 15, Issue 5, pp. 1970028 - n/a
Kuafu Chasing the Sun is a famous mythology story in China. Kuafu wished to capture the sun and he never ever gave up on that goal. In article number 1804191 ,... 
radiotherapy | cytopharmaceuticals | gastric cancer | Abraxane | human neutrophils | Drugs | Drug delivery systems | Adjuvant treatment | Radiotherapy | Stomach cancer | Cancer | Vehicles | Chemotherapy | Neutrophils | Radiation therapy | Sun
Journal Article
Skin Research, ISSN 1347-1813, 04/2013, Volume 12, Issue 2, pp. 79 - 82
Journal Article
Journal Article
Journal Article
Journal Article
Current Opinion in Solid State & Materials Science, ISSN 1359-0286, 12/2012, Volume 16, Issue 6, pp. 287 - 294
Journal Article
by Sun, XL and Yan, YJ and Liu, SL and Cao, QZ and Yang, M and Neamati, N and Shen, BZ and Niu, G and Chen, XY
JOURNAL OF NUCLEAR MEDICINE, ISSN 0161-5505, 01/2011, Volume 52, Issue 1, pp. 140 - 146
Abraxane (nanoparticle albumin-bound paclitaxel) is an anticancer drug approved by the Food and Drug Administration. However, the mechanism of action of... 
HEAD | positron emission tomography (PET) | INTEGRIN ALPHA(V)BETA EXPRESSION | TUMOR ANGIOGENESIS | ANTITUMOR | RGD | SMALL-ANIMAL PET | BREAST-CANCER | therapy response | Abraxane | ALBUMIN-BOUND PACLITAXEL | F-18-FDG | SQUAMOUS-CELL CARCINOMA | NECK | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
Journal Article
Journal Article